The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 497-503

  Chopra, Ian ^a   Hodgson, John ^b   Metcalf, Brian ^c   Poste, George ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SmithKline Beecham   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CHLORAMPHENICOL DERIVATIVE; CLAVULANIC ACID; IMIPENEM; LANKACIDIN; MOCIMYCIN; PLEUROMUTILIN; PSEUDOMONIC ACID; SIDEROMYCIN; SULTAMICILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; DIAGNOSTIC APPROACH ROUTE; DRUG DESIGN; DRUG MECHANISM; DRUG STABILITY; ENZYME INACTIVATION; GENE EXPRESSION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031037207     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.497     Document Type: Short Survey

References (72)

1. Allen, N. E. 1985. Nonclassical targets for antibacterial agents. Annu. Rep. Med. Chem. 20:155-162.
2. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
3. Braun V., and K. Hantke. 1981. Antimicrobial treatment via iron metabolism, p. 286-296. In L. Ninet, P. E. Bost, D. H. Bouanchaud, and J. Florent (ed.). The future of antibiotherapy and antibiotic research. Academic Press, London, United Kingdom.
4. Briat, J.-F. 1992. Iron assimilation and storage in prokaryotes. J. Gen. Microbiol. 138:2475-2483.
5. Camilli, A., D. T. Beattie, and J. J. Mekalanos. 1994. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA 91: 2634-2638.
6. Chopra, I. 1992. Efflux-based antibiotic resistance mechanisms: the evidence for increasing prevalence. J. Antimicrob. Chemother. 30:737-739.
7. Chopra, I., J. Hodgson, B. Metcalf, and G. Poste. 1996. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective. JAMA 275:401-403.
8. Chuang, S.-E., D. L. Daniels, and F. R. Blattner. 1993. Global regulation of gene expression in Eschcrichia coli. J. Bacteriol. 175:2026-2036.
9. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a postantimicrobial era. Science 257:1050-1055.
10. Coleman, K., M. Athalye, A. Clancey, M. Davison, D. J. Payne, C. R. Perry, and I. Chopra. 1994. Bacterial resistance mechanisms as therapeutic targets. J. Antimicrob. Chemother. 33:1091-1116.
11. Culotta, E. 1994. Funding crunch hobbles antibiotic resistance research. Science 264:362-363.
12. Donnelly, J. P., A. Voss, W. Witte, and B. Murray. 1996. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? J. Antimicrob. Chemother. 37:389-390.
13. Fischetti, V. A., V. Pancholi, and O. Schneewind. 1991. Common characteristics of the surface proteins from gram-positive cocci, p. 290-294. In G. M. Dunny, P. P. Cleary, and L. L. Mickey (ed.), Genetics and molecular biology of streptococci, lactococci and enterococci. American Society for Microbiology, Washington, D.C.
14. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, F. Kirkness, R. Kerlavage, J. Bull, F. Tomb, B. A. Dougherty, J. M. Merrick, K. McKenney, G. Sutton, W. Fitzhugh, C. Fields, D. Gocayne, J. Scott, R. Shirley, L.-I. Liu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman, J. L. Fuhrmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-312.
15. Fraser, C. M., J. D. Gocayne, O. White, M. D. Adams, R. A. Clayton, R. D. Fleischmann, C. J. Bult, A. R. Kerlavage, G. Sutton, J. M. Kelley, J. L. Fritchman, J. F. Weidman, K. V. Small, M. Sandusky, J. Fuhrmann, D. Nguyen, T. R. Utterback, D. M. Saudek, C. A. Phillips, J. M. Merrick, J.-F. Tomb, B. A. Dougherty, K. F. Bott, P.-C. Hu, T. S. Lucier, S. N. Peterson, H. O. Smith, C. A. Hutchison, and J. C. Venter. 1995. The minimal gene complement of Mycoplasma genitalium. Science 270:397-403.
16. Gale, E. F., E. Cundliffe, P. E. Reynolds, M. H. Richmond, and M. J. Waring. 1981. The molecular basis of antibiotic action. 2nd ed. John Wiley & Sons, London, United Kingdom.
17. Goward, C. R., M. D. Scawen, J. P. Murphy, and T. Atkinson. 1993. Molecular evaluation of bacterial cell-surface proteins. Trends Biochem. Sci. 18: 136-140.
18. Hammond, S. M., A. Claesson, A. M. Jansson, L.-G. Larsson, B. G. Pring, C. M. Town, and B. Ekstrom. 1987. A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis. Nature 327:730-732.
19. Hensel, M., J. E. Shea, C. Gleeson, M. D. Jones, E. Dalton, and D. W. Holden. 1995. Simultaneous identification of bacterial virulence genes by negative selection. Science 269:400-403.
20. Hughes, J., and G. Mellows. 1978. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J. Antibiot. 31:330-335.
21. Hughes, J., and G. Mellows. 1978. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem. J. 176: 305-318.
22. Jacobs, W. R., and B. R. Bloom. 1994. Molecular genetic strategies for identifying virulence determinants of Mycobacterium tuberculosis, p. 253-268. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. American Society for Microbiology, Washington, D.C.
23. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
24. Kaatz, G. W., and S. M. Seo. 1996. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:789-801.
25. Kikuta-Oshima, L. C., C. H. King, T. M. Shinnick, and F. D. Quinn. 1994. Methods for the identification of virulence genes expressed in Mycobacterium tuberculosis strain H37Rv. Ann. N.Y. Acad. Sci. 730:263-265.
26. Kuckers, A., and N. M. Bennett. 1987. The use of antibiotics, a comprehensive review with clinical emphasis, 4th ed. Heinemann, Oxford, United Kingdom.
27. Kopp, U., M. Roos, J. Wecke, and H. Labischinski. 1996. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microb. Drug Res. 2:29-41.
28. Kunin, C. M. 1993. Resistance to antimicrobial drugs - a world-wide calamity. Ann. Intern. Med. 118:557-561.
29. Levy, S. B. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36:695-703.
30. Livermore, D. M. 1992. Carbapenemases. J. Antimicrob. Chemother. 29: 609-613.
31. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
32. Mahan, M. J., J. M. Slauch, P. C. Hanna, A. Camilli, J. W. Tobias, M. K. Walder, and J. J. Mekalanos. 1993. Selection for bacterial genes that are specifically induced in host tissues: the hunt for virulence factors. Infect. Agents Dis. 2:263-268.
33. Mahan, M. J., J. M. Slauch, and J. J. Mekalanos. 1993. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259:686-688.
34. Mahan, M. J., J. W. Tobias, J. M. Slauch, P. C. Hanna, R. J. Collier, and J. J. Mekalanos. 1995. Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. Proc. Natl. Acad. Sci. USA 92:669-673.
35. Malanoski, G., L. Collins, C. T. Eliopoulos, R. C. Moellering, and G. M. Elliopoulos. 1995. Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria. Antimicrob. Agents Chemother 39:990-995.
36. Meinnel, T., Y. Mechulam, and S. Blanquet. 1995. Aminoacyl-tRNA synthetases: occurrence, structure, and function, p. 281-292. In D. Soll, and U. L. RajBhandary (ed.), tRNA: structure, biosynthesis and function. American Society for Microbiology, Washington, D.C.
37. Moellering, R. C., G. M. Eliopoulos, and D. E. Sentochnik. 1989. The carbapenems: new broad spectrum β-lactam antibiotics. J. Antimicrob. Chemother. 24(Suppl. A):1-7.
38. Navarre, W. W., and O. Schneewind. 1994. Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in gram-positive bacteria. Mol. Microbiol. 14:115-121.
39. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
40. Neuhaus, F. C., and N. Georgopapadakou. 1992. Strategies in β-lactam design, p. 205-273. In J. Sutcliffe, and N. H. Georgopapadakou (ed.), Emerging targets in antibacterial and antifungal chemotherapy. Chapman & Hall, New York, N.Y.
41. Nicas T. I., D. L. Mullen, J. E. Flokowitsch, D. A. Preston, N. J. Snyder, R. E. Stratford, and R. D. G. Cooper. 1995. Activities of the semi-synthetic glycopeptide LY 191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob. Agents Chemother. 39:2585-2587.
42. Omura, S. 1992. Trends in the search for bioactive microbial metabolites. J. Ind. Microbiol. 10:135-156.
43. Osbourn, A. E., C. E. Barber, and M. J. Daniels. 1987. Identification of plant-induced genes of the bacterial pathogen Xanthomonas campestris pathovar campestris using a promoter probe plasmid. EMBO J. 6:23-28.
44. Piddock, L. J. V. 1996. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? J. Antimicrob. Chemother. 38:1-3.
45. Plum, G., and J. E. Clark-Curtiss. 1994. Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect. Immun. 62:476-483.
46. Rankin, S., and R. R. Isberg. 1994. Identification of Legionella pneumophila promoters regulated by the macrophage intracellular environment. Infect. Agents Dis. 2:269-271.
47. Rasmussen, B. A., Y. Gluzman, and F. P. Tally. 1994. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob. Agents Chemother. 38:1658-1660.
48. Reading, C., and M. Cole. 1977. Clavulanic acid: a β-lactamase inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11:852-857.
49. Russell, A. D., and I. Chopra. 1996. Understanding antibacterial action ana resistance, 2nd ed. Ellis Horwood, New York, N.Y.
50. Sabath, L. D., C. Garner, C. Wilcox, and M. Finland. 1975. Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob. Agents Chemother. 8:344-349.
51. Schena, M.. D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
52. Shaw, W. V. 1984. Bacterial resistance to chloramphenicol. Br. Med. Bull. 40:36-41.
53. Shlaes, D., S. Levy, and G. Archer. 1991. Antimicrobial resistance: new directions. ASM News 57:455-458.
54. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Fortes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP105 and DuP721. Antimicrob. Agents Chemother. 31:1791-1797.
55. + antiporter. Antimicrob. Agents Chemother. 39:247-249.
56. Soothill, J. S. 1992. Treatment of experimental infections of mice with bacteriophages. J. Med. Microbiol. 37:258-261.
57. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1996. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:481-484.
58. Sumita, Y., H. Nouda, K. Kanazawa, and M. Fukasawa. 1995. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphyhcoccus aureus. Antimicrob. Agents Chemother. 39:910-916.
59. Sutcliffe, J. A. 1988. Novel approaches toward discovery of antibacterial agents. Annu. Rep. Med. Chem. 23:141-150.
60. Swartz, M. N. 1994. Hospital-acquired infections: diseases with increasingly limited therapies. Proc. Natl. Acad. Sci. USA 91:2420-2427.
61. Sykes, R. B., and D. P. Bonner. 1984. Counteracting antibiotic resistance: new drugs Br. Med. Bull. 40:96-101.
62. Tally, F. T., G. A. Ellestad, and R. T. Testa. 1995. Glycylcyclines: a new generation of tetracyclines. J. Antimicrob. Chemother. 35:449-452.
63. Tenover, F. C., and J. M. Hughes. 1996. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 275:300-304.
64. Tomasz, A. 1994. Multiple antibiotic-resistant pathogenic bacteria. N. Engl. J. Med. 330:1247-1251.
65. Tuckman, M. K., I. Chopra, and M. S. Osburne. 1994. An assay to detect inhibitors of bacterial iron transport. J. Antibiot. 47:123-125.
66. Utt, E. A., J. P. Brousal, L. C. Kikuta-Oshima, and F. D. Quinn. 1995. The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization. Can. J. Microbiol. 41:152-156.
67. Utt, E. A., and F. D. Quinn. 1994. mRNA subtractive hybridization for the isolation and identification of tissue culture-induced determinants from Haemophilus influenzae biogroup aegyptius, the causative agent of Brazilian purpuric fever. Ann. N.Y. Acad. Sci. 730:269-272.
68. Welsh, J., K. Chada, S. S. Dalal, R. Cheng, D. Ralph, and M. McClelland. 1992. Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res. 20:4965-4970.
69. Wilson, J. M., B. Oliva, R. Cassels, P. J. O'Hanlon, and I. Chopra. 1995. SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob. Agents Chemother. 39:1925-1933.
70. Wong K. K., and M. McClelland. 1994. Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA. Proc. Natl. Acad. Sci. USA 91:639-643.
71. Yang, Y., N. Bhachech, and K. Bush. 1995. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by β-lactamases. J. Antimicrob. Chemother. 35:75-84.
72. Zahner, H., and H.-P. Fiedler. 1995. The need for new antibiotics: possible ways forward. In P. A. Hunter, G. K., Darby and N. J. Russell (ed.), Fifty years of antimicrobials: past perspectives and future trends. In Fifty-Third Symposium of the Society for General Microbiology. Cambridge University Press, Cambridge. United Kingdom.